
zzso and zzso zzso are zzso zzso a second-generation zzso zzso which zzso zzso produced by the DNA zzso zzso for the potential treatment of solid zzso A phase II trial in zzso or zzso zzso cell cancer of the head and neck was initiated in November 2000 zzso and a phase II trial in patients with advanced and/or zzso zzso cell zzso was initiated in August 2001 zzso In November 2001, a company representative stated that phase II data would be available in the first half of 2002 zzso In April 2001, zzso received zzso entitled zzso of DNA zzso This patent covers the administration of an agent that could help the human body to restore normally occurring mechanisms to combat or terminate the growth of zzso tumors zzso zzso The company has also been awarded zzso zzso zzso zzso zzso sequences and zzso zzso and zzso zzso claiming zzso zzso zzso complementary to DNA zzso sequences zzso zzso 

